메뉴 건너뛰기
Journal of Hepatology
Volumn 58, Issue 6, 2013, Pages 1262-1264
Efficacy of interferon-based antiviral therapy on the risk of hepatocellular carcinoma of patients with chronic hepatitis C: Further evidence in decompensation cirrhosis
Author keywords

[No Author keywords available]
Indexed keywords

ALPHA2B INTERFERON; PEGINTERFERON ALPHA2B; RIBAVIRIN; ALPHA INTERFERON; ANTIVIRUS AGENT; MACROGOL DERIVATIVE;
EID: 84877924136     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2013.01.041     Document Type: Letter
Times cited : (10)
References (10)
  • 1
    • 84874117560 scopus 로고    scopus 로고
    • Efficacy of pegylated interferon alpha-2b and ribavirin treatment on the risk of hepatocellular carcinoma of patients with chronic hepatitis C: A prospective, multicenter study
    • E. Ogawa, N. Furusyo, E. Kajiwara, K. Takahashi, H. Nomura, and T. Maruyama Efficacy of pegylated interferon alpha-2b and ribavirin treatment on the risk of hepatocellular carcinoma of patients with chronic hepatitis C: a prospective, multicenter study J Hepatol 58 2013 495 501
    • (2013) J Hepatol , vol.58 , pp. 495-501
    • Ogawa, E.1    Furusyo, N.2    Kajiwara, E.3    Takahashi, K.4    Nomura, H.5    Maruyama, T.6
  • 2
    • 33845647232 scopus 로고    scopus 로고
    • Peginterferon alfa-2b and ribavirin in patients with hepatitis C virus and decompensated cirrhosis: A controlled study
    • A. Iacobellis, M. Siciliano, F. Perri, B.E. Annicchiarico, G. Leandro, and N. Caruso Peginterferon alfa-2b and ribavirin in patients with hepatitis C virus and decompensated cirrhosis: a controlled study J Hepatol 46 2007 206 212
    • (2007) J Hepatol , vol.46 , pp. 206-212
    • Iacobellis, A.1    Siciliano, M.2    Perri, F.3    Annicchiarico, B.E.4    Leandro, G.5    Caruso, N.6
  • 3
    • 84555218832 scopus 로고    scopus 로고
    • Short-term efficacy and safety of standard interferon with a low accelerating dosage regimen in HCV-related decompensated cirrhosis
    • F.P. Ji, Z.X. Li, Z.F. Cai, C.Y. Tian, H.A. Xue, and G.Y. Pan Short-term efficacy and safety of standard interferon with a low accelerating dosage regimen in HCV-related decompensated cirrhosis Zhonghua Gan Zang Bing Za Zhi 18 2010 946 948
    • (2010) Zhonghua Gan Zang Bing Za Zhi , vol.18 , pp. 946-948
    • Ji, F.P.1    Li, Z.X.2    Cai, Z.F.3    Tian, C.Y.4    Xue, H.A.5    Pan, G.Y.6
  • 4
    • 79960453276 scopus 로고    scopus 로고
    • EASL clinical practice guidelines: Management of hepatitis C virus infection
    • European Association For The Study Of The Liver
    • European Association for the Study of the Liver EASL clinical practice guidelines: management of hepatitis C virus infection J Hepatol 55 2011 245 264
    • (2011) J Hepatol , vol.55 , pp. 245-264
  • 5
    • 19944428400 scopus 로고    scopus 로고
    • Antiviral therapy for cirrhotic hepatitis C: Association with reduced hepatocellular carcinoma development and improved survival
    • Y. Shiratori, Y. Ito, O. Yokosuka, F. Imazeki, R. Nakata, and N. Tanaka Antiviral therapy for cirrhotic hepatitis C: association with reduced hepatocellular carcinoma development and improved survival Ann Intern Med 142 2005 105 114
    • (2005) Ann Intern Med , vol.142 , pp. 105-114
    • Shiratori, Y.1    Ito, Y.2    Yokosuka, O.3    Imazeki, F.4    Nakata, R.5    Tanaka, N.6
  • 6
    • 77956635697 scopus 로고    scopus 로고
    • Outcome of sustained virological responders with histologically advanced chronic hepatitis C
    • T.R. Morgan, M.G. Ghany, H.Y. Kim, K.K. Snow, M.L. Shiffman, and J.L. De Santo Outcome of sustained virological responders with histologically advanced chronic hepatitis C Hepatology 52 2010 833 844
    • (2010) Hepatology , vol.52 , pp. 833-844
    • Morgan, T.R.1    Ghany, M.G.2    Kim, H.Y.3    Snow, K.K.4    Shiffman, M.L.5    De Santo, J.L.6
  • 7
    • 79951704255 scopus 로고    scopus 로고
    • Long-term outcome after antiviral therapy of patients with hepatitis C virus infection and decompensated cirrhosis
    • A. Iacobellis, F. Perri, M.R. Valvano, N. Caruso, G.A. Niro, and A. Andriulli Long-term outcome after antiviral therapy of patients with hepatitis C virus infection and decompensated cirrhosis Clin Gastroenterol Hepatol 9 2011 249 253
    • (2011) Clin Gastroenterol Hepatol , vol.9 , pp. 249-253
    • Iacobellis, A.1    Perri, F.2    Valvano, M.R.3    Caruso, N.4    Niro, G.A.5    Andriulli, A.6
  • 8
    • 70349292099 scopus 로고    scopus 로고
    • Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
    • D. Ge, J. Fellay, A.J. Thompson, J.S. Simon, K.V. Shianna, and T.J. Urban Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance Nature 461 2009 399 401
    • (2009) Nature , vol.461 , pp. 399-401
    • Ge, D.1    Fellay, J.2    Thompson, A.J.3    Simon, J.S.4    Shianna, K.V.5    Urban, T.J.6
  • 9
    • 83555174789 scopus 로고    scopus 로고
    • Interleukin-28B genetic variants in identification of hepatitis C virus genotype 1 patients responding to 24 weeks peginterferon/ribavirin
    • C.F. Huang, J.F. Huang, J.F. Yang, M.Y. Hsieh, Z.Y. Lin, and S.C. Chen Interleukin-28B genetic variants in identification of hepatitis C virus genotype 1 patients responding to 24 weeks peginterferon/ribavirin J Hepatol 56 2012 34 40
    • (2012) J Hepatol , vol.56 , pp. 34-40
    • Huang, C.F.1    Huang, J.F.2    Yang, J.F.3    Hsieh, M.Y.4    Lin, Z.Y.5    Chen, S.C.6
  • 10
    • 78649320722 scopus 로고    scopus 로고
    • Role of interleukin-28B polymorphisms in the treatment of hepatitis C virus genotype 2 infection in Asian patients
    • M.L. Yu, C.F. Huang, J.F. Huang, N.C. Chang, J.F. Yang, and Z.Y. Lin Role of interleukin-28B polymorphisms in the treatment of hepatitis C virus genotype 2 infection in Asian patients Hepatology 53 2011 7 13
    • (2011) Hepatology , vol.53 , pp. 7-13
    • Yu, M.L.1    Huang, C.F.2    Huang, J.F.3    Chang, N.C.4    Yang, J.F.5    Lin, Z.Y.6

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.